Clinica Respira-Dr. Juanola
- Address
- c/ d'Argentona, 84, 08302 Mataró, Spain
Respiratory Research – COPD
The Neumologia department at Clinica Respira-Dr. Juanola is conducting studies on Chronic Obstructive Pulmonary Disease, aiming to test new inhaled treatments that may improve breathing and daily function.
- Inhaled medication efficacy
- Lung function preservation
- Patient‑reported outcome improvement
These investigations support the site’s focus on advancing care for patients with respiratory tract disorders in Europe.
Severe Uncontrolled Asthma Studies
At this Mataró‑based centre, researchers are evaluating innovative adjunctive therapies for severe uncontrolled asthma, with the goal of lowering exacerbation rates and enhancing quality of life.
- Adjunctive biologic therapy assessment
- Reduction of clinically significant exacerbations
- Long‑term safety and tolerability monitoring
The work reflects a commitment to addressing challenging asthma cases within the broader field of respiratory tract diseases.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Generate Biomedicines Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Clinica Respira-Dr. Juanola
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 2a, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Fexlamose (AER 01) Inhalation Solution in the Treatment of Adults with Moderate to Severe Chronic Obstructive Pulmonary Disease | Aer Therapeutics Inc. | Phase II | Not Recruiting | Mar 2026 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 6-THIO-ALFA-D-GLUCOPYRANOSYL 6-THIO-ALFA-D-GLUCOPYRANOSIDE | 1 | Unknown | 2026-03-04 | 2026-03-04 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.